Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Trichomonas vaginalis is a protozoan parasite characterized by its four flagella, primarily residing in the genital tract. It is recognized as the most prevalent non-viral sexually transmitted infection (STI), often presenting without symptoms, which can lead to significant health risks. These risks include an increased susceptibility to HIV infection and the potential development of cervical neoplasia. The CPT® Code 87808 pertains to the detection of this infectious agent through an immunoassay method that utilizes direct optical observation. This testing process typically involves collecting a clinical sample, frequently through vaginal swabbing. The sample is then subjected to a series of steps involving incubation with antibodies specifically designed to bind to Trichomonas vaginalis. Following this, the antigen-antibody complex is formed, and subsequent washing and probing steps are performed to quantify the presence of the parasite. The final measurement of Trichomonas vaginalis is determined by assessing the optical density, which correlates with the amount of the antigen present in the sample, providing a clear and direct method for diagnosis.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87808 is indicated for the detection of Trichomonas vaginalis in patients who may present with symptoms or are at risk for this infection. The following conditions warrant the use of this immunoassay:
The procedure for CPT® Code 87808 involves several critical steps to ensure accurate detection of Trichomonas vaginalis. The following outlines the procedural steps:
After the completion of the immunoassay procedure for CPT® Code 87808, the results are analyzed and interpreted. It is essential to communicate the findings to the patient and discuss any necessary follow-up actions, which may include treatment options if Trichomonas vaginalis is detected. Patients may also be advised on safe sexual practices to prevent reinfection or transmission. Additionally, healthcare providers should consider retesting in cases of persistent symptoms or if the patient has ongoing risk factors for STIs. Proper documentation of the results and any subsequent actions taken is crucial for maintaining accurate medical records and ensuring continuity of care.
| Short Descr | TRICHOMONAS ASSAY W/OPTIC | Medium Descr | IAADIADOO TRICHOMONAS VAGINALIS | Long Descr | Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Trichomonas vaginalis | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | Yes | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| QW | Clia waived test | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GC | This service has been performed in part by a resident under the direction of a teaching physician | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2022-01-01 | Changed | First appearance of change in codebook. |
| 2021-01-01 | Changed | First appearance of change in CPT® Code Set. |
| 2020-10-06 | Changed | Code description changed. |
| 2007-01-01 | Added | First appearance in code book in 2007. |
Get instant expert-level medical coding assistance.